Interoperability of RTN1A in dendrite dynamics and immune functions in human Langerhans cells

  1. Małgorzata Anna Cichoń
  2. Karin Pfisterer
  3. Judith Leitner
  4. Lena Wagner
  5. Clement Staud
  6. Peter Steinberger
  7. Adelheid Elbe-Bürger  Is a corresponding author
  1. Department of Dermatology, Medical University of Vienna, Austria
  2. Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Austria
  3. Department of Plastic and Reconstructive Surgery, Medical University of Vienna, Austria
9 figures, 1 table and 1 additional file

Figures

Figure 1 with 1 supplement
Impairment of Reticulon 1A (RTN1A) functionality instigates a roundish morphology in resident Langerhans cells (rLCs).

(A) Experimental workflow demonstrating the cultivation of human epidermal sheets with an α-RTN1A antibody (ab) and the isotype for indicated time points and subsequent analysis strategies. (B–C) Representative immunofluorescence (IF) images of isotype- and α-RTN1A-treated epidermal sheets at indicated time points stained for CD207 (green), a secondary ab (red) to visualize the uptake of the isotype and α-RTN1A ab by rLCs and nuclear counterstaining with 4′,6-diamidino-2-phenylindole (DAPI) (blue). Zoom-ins of the boxed areas are also shown as 3D projections underneath. RTN1A+ rLCs: yellow arrows, RTN1A- rLCs: white arrows. n=3, scale bar: 20 μm. (D) Representative IF images showing RTN1A, CD207, vimentin, and DAPI staining in untreated (UT), isotype- and α-RTN1A-treated human epidermal sheets after 24 hr of cultivation. Co-localization of RTN1A with vimentin: pinkish arrows, rLCs with partially retracted dendrites: white arrows. n=4, scale bar: 20 μm. (E, F) Enumeration, percentage, and distribution of dendritic and roundish rLCs in epidermal sheets upon 24 hr of culture and indicated treatment. (E) Data are shown as standard error of the mean (SEM) from four fields of view (FOVs) of four donors and were analyzed using two-way ANOVA with Tukey’s multiple-comparison test. (F) Data represent mean of four donors. *p≤0.05, **p≤0.01.

Figure 1—figure supplement 1
The frequency of RTN1A protein expression in resident Langerhans cells (rLCs) and emigrated LCs (eLCs).

(A.) Percentage of total Reticulon 1A+ (RTN1A+) resident Langerhans cells (rLCs) and emigrated LCs (eLCs), analyzed with flow cytometry. Viable rLCs and eLCs were gated for CD1a and CD207. Data shown as standard error of the mean (SEM), each dot represents one donor. rLCs: n=4, eLCs = n = 5. (B, C) Frequency of RTN1A expression in LCs. Representative dot blots showing flow cytometry analysis of (B) freshly isolated rLCs and (C) eLCs, stained for CD207, CD1a, and RTN1A. Quantification of the percentage of double-positive LCs s shown. Data shown as standard error of the mean (SEM), each dot represents one donor. CD207: n=2–4, CD1a: n=5.

Inhibition of Reticulon 1A (RTN1A) in resident Langerhans cells (rLCs) significantly alters dendrite length and distribution.

(A) 3D projections of epidermal sheets upon 24 hr of culture, indicated treatment, and vimentin (VIM) staining (left panel). Shown are single rLC 3D trajectories based on intermediate filament expression (right panel). Scale bar: 10 μm. (B, C) Evaluation of the average rLC branch lengths and Sholl analysis of rLC dendricity upon 24 hr of culture and indicated treatments. Four fields of view (FOVs) were evaluated of four donors and data analyzed using two-way ANOVA with Tukey‘s multiple-comparison test, ns = not significant. *p≤0.05, ****p≤0.0001.

Hampering Reticulon 1A (RTN1A) function decreases the Langerhans cell (LC) migration potential and alters the marker expression in emigrated LCs (eLCs).

(A, B) Enumeration and ab uptake of pre-gated CD207+CD1a+ eLCs, collected from culture wells with epidermal sheets at indicated time points and analyzed via flow cytometry. (A) Data are presented as standard error of the mean (SEM) from triplicates of three donors. Ordinary one-way ANOVA with Tukey’s multi-comparison test was used. *p≤0.05. (B) Data from triplicates, including three donors, are shown as mean fold change to untreated (UT) eLCs. (C) Marker expression profile of pre-gated CD207+ eLCs upon 24 hr of culture, treatment, and flow cytometry analysis. Data shown represent mean ± SEM of three donors and were analyzed using two-way ANOVA Tukey’s multi-comparison test. *p≤0.05. (D) Adhesion molecule concentrations in supernatants of cultivated epidermal sheets with indicated 24 hr treatments and subsequent LEGENDplex bead array measurement. Data are shown as SEM from duplicates of four donors and were analyzed using two-way ANOVA with Tukey’s multiple-comparison test. *p≤0.05, **p≤0.01.

Figure 4 with 1 supplement
Expression of Reticulon 1A (RTN1A) in the myeloid THP-1 cell line affects the cell size.

(A) Workflow for the generation of THP-1 RTN1A+ cells and their comparative analysis with THP-1 wild-type (wt) cells. (B) Representative immunofluorescence (IF) images of THP-1 wt and THP-1 RTN1A+ cells on adhesion slides stained for RTN1A, vimentin (VIM), and nuclei (4′,6-diamidino-2-phenylindole [DAPI]). n=4; scale bar: 10 μm. (C) Comparative evaluation of the cell area revealed substantial divergences between THP-1 wt and THP-1 RTN1A+ cells. Data are shown as standard error of the mean (SEM) from four fields of view (FOVs; n=4) and were analyzed using unpaired, two-tailed Student’s t test. ****p≤0.0001. (D, E) Representative IF images and quantification using Manders’ coefficient of RTN1A co-localization with filamentous proteins in a THP-1 RTN1A+ cell within three-cell compartments: bottom, middle, and top of the cell (right panel). Scale bar: 10 μm. Data are shown as SEM (10 cells/4 FOVs; n=2), and analyzed using two-way ANOVA with Tukey‘s multiple-comparison test. *p≤0.05, ****p≤0.0001. (F) Evaluation of the cell number and proliferation rate of THP-1 wt and THP-1 RTN1A+ cells within the time period indicated. Data presented as SEM were analyzed with two-way ANOVA, Sidak’s multiple-comparison test (n=3). *p<0.05, **p≤0.01, ***p≤0.001.

Figure 4—figure supplement 1
Expression of RTN1A in THP-1 cells leads to constriction of intermediate filaments and their colocalization with RTN1A.

(A) Representative immunofluorescence (IF) images of THP-1 wild-type (wt) and THP-1 Reticulon 1A+ (RTN1A+) cells on adhesion slides stained with vimentin (VIM) and demonstrated as LUT-fire. THP-1 RTN1A+ cells display markedly more condensed intermediate filament structures in comparison to THP-1 wt cells. Scale bar: 10 μm. (B) Representative IF image of THP-1 RTN1A+ cells stained for RTN1A, F-actin, VIM, and nuclei. Image is shown as montage of Z-stack slices.

Figure 5 with 1 supplement
Reticulon 1A (RTN1A) considerably alters the morphology of THP-1 RTN1A+ macrophages (Mφs) as well as enhances aggregate formation and impairs Ca2+ flux in THP-1 RTN1A+ cells.

(A) Workflow for the differentiation and comparative analysis of THP-1 RTN1A+ Mφs and THP-1 wild-type (wt) Mφs. (B) Representative bright-field (BF) and immunofluorescence images (IF; co-staining with RTN1A, F-actin, vimentin [VIM], and 4′,6-diamidino-2-phenylindole [DAPI]) of THP-1 wt Mφs and THP-1 RTN1A+ Mφs. Scale bar: BF: 31 and IF: 10 μm, n=4. (C, D) Comparative analysis of cell body size and average length of cell protrusions of differentiated THP-1 wt Mφs and THP-1 RTN1A+ Mφs. Data were analyzed using unpaired, two-tailed Student’s t test, n=4. ****p≤0.0001. (E) Comparative co-localization between RTN1A, F-actin, and VIM using Manders’ coefficient. Data shown are standard error of the mean (SEM), n=4. ****p≤0.0001. (F) Representative BF image of THP-1 wt and THP-1 RTN1A+ cells forming aggregates during culture. Scale bar: 100 µm. (G) Enumeration of THP-1 wt and THP-1 RTN1A+ cell aggregates. Data are demonstrated as SEM from four fields of view per passage and analyzed using unpaired, two-tailed Student’s t test, n=6. (H) Adhesion molecule concentrations in supernatants after 48 hr of THP-1 wt and THP-1 RTN1A+ cell cultivation, measured in duplicates with LEGENDplex bead array. Data are shown as SEM from three different passages and were analyzed using unpaired, two-tailed Student’s t test. *p≤0.05. (I, J) Ratiomeric analysis of early and late phase calcium flux in THP-1 wt and THP-1 RTN1A+ cells using Fura-3 calcium indicator, ionomycin (n=5), and thapsigargin (n=4). Unpaired two-tailed t test was used for the response to both ionomycin and thapsigargin. ****p≤0.0001.

Figure 5—figure supplement 1
Enumeration of small and big THP-1 wild-type (wt) and THP-1 Reticulon 1A+ (RTN1A+) cell aggregates per 0.7 mm2 from four fields of view (FOVs).

The size of cellular aggregates was defined based on their area (small ~312.5 µm2 and big ~637.6 µm2). n=6.

Figure 6 with 1 supplement
Emigrated LCs (eLCs) significantly decrease Reticulon 1A (RTN1A) expression upon stimulation with TLR1/2, TLR2, and TLR7 agonists.

(A) Graphical presentation for the stimulation of epidermal sheets with TLR agonists and analysis. (B) Representative FACS blots of RTN1A expression in pre-gated eLCs upon stimulation of epidermal sheets with TLR1/2 (Pam3CSK4), TLR2 (Listeria monocytogenes), TLR2/6 (mycoplasma salivarium), TLR7 (imiquimod), TLR3/7 [polyadenylic:polyuridylic acid (poly(A:U))], and TLR3 [low and high molecular weight polyinosinic:polycytidylic acid (LMW and HMW poly(I:C))] for 24 hr. (C, D) The percentage and geometric mean fluorescence intensity (gMFI) of RTN1A in eLCs are shown as standard error of the mean (SEM) of triplicates, and analyzed using two-way ANOVA with Tukey‘s multiple-comparison test. *p≤0.05, **p≤0.01, ***p≤0.001. Some p values were not significant (ns), yet indicative of a trend for the reduction of RTN1A expression intensity. (E) Recovery of the RTN1A protein expression (% of RTN1A+ eLCs) after 48 hr of cultivation with indicated TLR agonists. Data shown represent mean ± SEM of triplicates from three donors.

Figure 6—figure supplement 1
Expression pattern of RTN1A protein within TLR-activated eLCs and their quantification.

(A) Gating strategy for emigrated Langerhans cells (eLCs) as analyzed with flow cytometry. (B, C) Reticulon 1A (RTN1A) distribution within TLR-activated eLCs and their quantification. Data shown represent mean ± standard error of the mean (SEM) of triplicates from four donors. Data set was analyzed using two-way ANOVA, Dunnett’s multiple-comparison test. *p0.05.

Figure 7 with 1 supplement
Stimulation of epidermal sheets with TLR1/2, TLR2, and TLR7 agonists initiates cluster formation of resident Langerhans cells (rLCs).

(A) Representative immunofluorescence (IF) images of untreated (control) and indicated TLR-treated epidermal sheets upon 24 hr of culture stained with Reticulon 1A (RTN1A) (red), CD83, CD86 (green), and 4′,6-diamidino-2-phenylindole (DAPI) (blue). n=5, scale bar: 20 μm. (B) 3D projection of rLCs in an epidermal sheet after incubation with a TLR7 agonist for 24 hr (A). rLCs form big (arrow) and small (asterisk) clusters yet were also visible as single activated dendritic rLCs (hashtag). (C, D) Expression intensity of indicated markers in rLCs upon culture and treatment. Data are shown as standard error of the mean (SEM) representing four fields of view of five donors, analyzed with two-way ANOVA Tukey’s multiple-comparison test. *p0.05,***p0.001. (E) Representative IF images of untreated (control) and TLR-stimulated epidermal sheets stained for MMP-9, CCR-7, and 4′,6-diamidino-2-phenylindole (DAPI). n=2, scale bar: 20 μm. (F) Inflammatory cyto- and chemokine concentrations in supernatants of epidermal sheet cultures after 24 hr, measured in duplicates with LEGENDplex bead array. Data are shown as SEM of four donors and analyzed using two-way ANOVA with Durrett’s multiple-comparison test. *p0.05, **p0.01.

Figure 7—figure supplement 1
Resident Langerhans cells (rLCs) do not proliferate in clusters upon TLR stimulation and produce elevated levels of IL-10 and IL-23.

(A) Representative immunofluorescence images of epidermal sheets after 24 hr of cultivation only or treatment with TLR 1/2, and TLR7 agonists. Epidermal sheets were stained for Ki67 (green) and nuclei (blue). n=2, scale bar: 20 μm. (B,C) Inflammatory cyto- and chemokines concentration measured in supernatants of epidermal sheet cultures after 24 hr, with LEGENDplex bead array. Data are shown as SEM from four donors and analyzed using two-way ANOVA with Durrett’s multiple-comparison test and were not significant.

Summary and overview on the function of Reticulon 1A (RTN1A).

Inhibition of RTN1A protein in resident Langerhans cells (LCs) in human epidermis ex vivo caused dendrite retraction, induced cell adhesion, and reduced LC migration. Stimulation of LCs with TLR agonists downregulated RTN1A expression and induced cluster formation (upper panel). Furthermore, expression of RTN1A in THP-1 cells altered cell size, morphology, calcium release from endoplasmic reticulum (ER) stores and cell aggregation in vitro (lower panel).

Author response image 1

Tables

Key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
Gene (Homo sapiens)RTN1ANM_0211369,
Eurofins (this paper)
Cell line (Homo sapiens)THP-1ATCCTIB-202
Transfected construct (Homo sapiens)pHR‐SIN‐BX‐IRES‐EmeraldPaster et al., 2013Lentiviral construct to
transfect the THP-1 cell line and express RTN1A
Antibodyα-RTN1A
(clone: mon162),
unconjugated
(Mouse monoclonal)
abcamab9274IF staining –
0.2 µg/ml; cultivation of epidermal sheets –
5 µg/ml/
Antibodyα-RTN1A
(clone: mon162),
unconjugated
(Mouse monoclonal)
Novus Biologicals, BiotechneNBP1-97677IF staining –
0.2 µg/ml; cultivation of epidermal sheets –
5 µg/ml/
Antibodyα-RTN1A-APC
(clone: mon161,
Mouse monoclonal)
Novus Biologicals, BiotechneNBP1-97678AF647FACS analysis – 1:500
AntibodyIgG1 [15-6E10A7] -
Isotype control,
unconjugated
(Mouse monoclonal)
abcamab170190IF staining –
0.2 µg/ml;
cultivation of
epidermal sheets –
5 µg/ml/
Antibodyα-CD207-FITC (clone
929F3.01, Rat monoclonal)
DendriticsCat:DDX0362IF staining – 0.25 µg/ml. 1:250
Antibodyα-CD207, unconjugated
(Rabbit monoclonal)
Sigma-AldrichHPA011216IF staining – 1:200
Antibodyα-Human CD207-
PE (clone DCGM4, Mouse)
Beckman CoulterPN IM3577FACS analysis – 1:200
Antibodyα-Human HLA-
DR-PE (Mouse)
BD PharmingenCat. 347401FACS analysis – 1:100
Antibodyα-Human CD1a-
PE (Mouse)
BD PharmingenCat. 555807FACS analysis – 1:100
Antibodyα-Human CD83-
FITC (Mouse)
BD PharmingenCat. 556910FACS analysis, IF staining – 1:100
Antibodyα-Human CD86-
FITC (Mouse)
BD PharmingenCat. 555657FACS analysis, IF staining – 1:100
Antibodyα-CCR7-APCMiltenyi Biotech5171113456FACS analysis, IF staining – 1:100
AntibodyRecombinant α-
Vimentin-FITC
(clone REA409)
Miltenyi Biotec130-116-508IF staining – 1:50
AntibodyRecombinant FITC
isotype control
Miltenyi Biotech130-113-449IF staining – 1:50
AntibodyF(ab')2-Goat anti-
Rabbit IgG (H+L)
Cross-Adsorbed
Secondary Antibody,
Alexa Fluor 488
Life TechnologiesREF A-11070IF staining – 1:500
AntibodyF(ab')2-Goat anti-
Mouse IgG (H+L)
Cross-Adsorbed
Secondary Antibody,
Alexa Fluor 546
Invitrogen, Thermo Fisher ScientificREF A-11018IF staining – 1:500
AntibodyAlexa Flour 647F(ab´)
2 fragment of goat
α-rabbit IgG (H+L)
Invitrogen, Thermo Fisher ScientificREF A-21246IF staining – 1:500
Commercial assay or kitHuman TLR kitInvitroGenCat. tlrl-kit1hw
Commercial assay or kitLEGENDplex
Human inflammatory
Panel 1 (13-plex) w/VbP
BiolegendCat. 740809
Commercial assay or kitLEGENDplex
Human Adhesion
Molecule Panel
(13-plex) w/VbP
BiolegendCat. 740946
Chemical compound, drugThapsigarginInvitrogen, Thermo Fisher ScientificT7458
Software, algorithmGraphPad Prism v8.0.1GraphPad Software
Software, algorithmFlowJo v10.6.1BD (Becton, Dickinson & Company)
Software, algorithmFiji: ImageJSchindelin et al., 2012
Software, algorithmImarisViewer 9.8Oxford Instruments
Software, algorithmAdobe Illustrator CS7Adobe Inc
OtherAlexa Fluor
647 Phalloidin
InvitrogenREF A-22287IF staining – 1:500
OtherFixable Viability
Dye eFluor 450
eBioscienceCat. 65-0863-18FACS analysis – 1:1000
OtherDAPI (4′,6-diamidino-
2-phenylindole dihydrochloride)
Sigma-AldrichCat. D9542IF staining – 1:5000
OtherDispase II (neutral
protease, grade II)
Roche Diagnostics049420780011.2 U/ml
OtherProLong Gold
antifade reagent
InvitroGenCat. P36934
OtherIC Fixation BuffereBioscienceCat. 00-8222-49
OtherPermeabilization Buffer (×10)eBioscienceCat. 00-8333-56
OtherPhorbol 12-myristate
13-acetate (PMA), PKC activator
AbcamAb120297
OtherTriton X-100Sigma-AldrichT9284
OtherFura Red, AM,
cell permeant
Invitrogen, Thermo Fisher ScientificF3020
OtherCellTrace CFSE Cell
Proliferation Kit, for
flow cytometry
Invitrogen, Thermo Fisher ScientificC34554
OtherIonomycin- Calcium ionophore
– NFAT Activator
InvivoGeninh-ion
OtherFibronectin Solution HumanPromoCellCat. C-43060

Additional files

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Małgorzata Anna Cichoń
  2. Karin Pfisterer
  3. Judith Leitner
  4. Lena Wagner
  5. Clement Staud
  6. Peter Steinberger
  7. Adelheid Elbe-Bürger
(2022)
Interoperability of RTN1A in dendrite dynamics and immune functions in human Langerhans cells
eLife 11:e80578.
https://doi.org/10.7554/eLife.80578